cckinase, Inc.

Favorite  |  Set Home
E-mail: info@cckinase.com
Products > Apoptosis > Bcl-2 inhibitor > A-1331852 (A1331852, A 1331852)
A-1331852 (A1331852, A 1331852)
Product name : A-1331852 (A1331852, A 1331852)
Product No. : 20171225528
Price : 100mg/$675; 500mg/$1875
CAS : 
Bulk inquiry : 
←[Previous Product]              [Next Product]→
Online Inquiry         Email Us

  Details:
A-1331852 (CAS: 1430844-80-6) is an orally available BCL-XL selective inhibitor with a Ki of less than 10 pM.  BCL-XL-selective inhibitors have the potential to enhance the efficacy of docetaxel in solid tumors and avoid the exacerbation of neutropenia observed with navitoclax. A-1331852 may have potential as improved cancer therapeutics.

  Related Products :

Mcl-IN-2
Mcl-IN-2
Price: 100mg, $675, 500mg/$1875

ABT-263 (Navitoclax, ABT263)
ABT-263 (Navitoclax, ABT263)
Price: 500mg, $975

A-1210477 (A1210477)
A-1210477 (A1210477)
Price: 100mg, $475, 500mg/$1275

ABT-737 (ABT737)
ABT-737 (ABT737)
Price: 100mg, $475, 500mg/$1275

ABT 737
ABT 737
Price: 100mg, $475, 500mg/$1275

S-63845 (S63845, S 63845)
S-63845 (S63845, S 63845)
Price: 100mg/$975, 500mg/$2875

WEHI-539 (WEHI539, WEHI 539)
WEHI-539 (WEHI539, WEHI 539)
Price: 100mg, $675, 500mg/$1875

AMG-176 (AMG176, AMG 176)
AMG-176 (AMG176, AMG 176)
Price: 10mg/$975, 100mg$4875

Online service

info@cckinase.com